Glenmede Trust CO Na Astrazeneca PLC Transaction History

Glenmede Trust CO Na

$18.2 Billion
Q1 2025

A detailed history of Glenmede Trust CO Na transactions in Astrazeneca PLC stock. As of the latest transaction made, Glenmede Trust CO Na holds 124,666 shares of AZN stock, worth $11.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

124,666

Previous 125,755 0.87%

Holding current value

$11.1 Million

Previous $8.24 Million 11.2%

% of portfolio

0.05%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $71,187 - $84,898	-1,089 Reduced 0.87%	124,666 $9.16 Million
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $4.13 Million - $5.2 Million	-65,377 Reduced 34.21%	125,755 $8.24 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $521,969 - $596,516	6,808 Added 3.69%	191,132 $14.9 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $373,000 - $451,273	-5,583 Reduced 2.94%	184,324 $14.4 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $903,060 - $1.03 Million	-14,797 Reduced 7.23%	189,907 $12.9 Million

Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $13,430 - $15,033	-217 Reduced 0.11%	204,704 $13.8 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $2.88 Million - $3.18 Million	-44,396 Reduced 17.81%	204,921 $13.9 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $543,153 - $615,831	8,601 Added 3.57%	249,317 $17.3 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $630,733 - $819,569	11,635 Added 5.08%	240,716 $16.3 Million
Q3 2022 Nov 16, 2022	BUY	$53.02 - $135.75 $1.1 Million - $2.81 Million	20,717 Added 9.94%	229,081 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.18 Million - $1.41 Million	19,889 Added 10.55%	208,364 $13.8 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $291,248 - $350,836	5,227 Added 2.85%	188,475 $12.5 Million
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $732,997 - $866,109	-13,569 Reduced 6.89%	183,248 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $813,009 - $889,540	14,633 Added 8.03%	196,817 $11.8 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $875,627 - $1.09 Million	-18,084 Reduced 9.03%	182,184 $10.9 Million
Q1 2021 May 18, 2021	BUY	$47.16 - $54.44 $2.74 Million - $3.16 Million	58,078 Added 40.85%	200,268 $9.96 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $232,459 - $277,973	4,791 Added 3.49%	142,190 $7.11 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $83,160 - $95,743	1,567 Added 1.15%	137,399 $7.53 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $783,213 - $1.01 Million	-18,172 Reduced 11.8%	135,832 $7.18 Million
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $37,407 - $44,455	881 Added 0.58%	154,004 $7.68 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $382,664 - $433,692	-9,538 Reduced 5.86%	153,123 $6.82 Million
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $91,112 - $101,865	-2,444 Reduced 1.48%	162,661 $6.71 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $347,695 - $421,466	-9,797 Reduced 5.6%	165,105 $6.67 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $1.45 Million - $1.63 Million	-39,221 Reduced 18.32%	174,902 $6.64 Million
Q3 2018 Nov 15, 2018	SELL	$34.76 - $39.72 $158,192 - $180,765	-4,551 Reduced 2.08%	214,123 $8.47 Million
Q2 2018 Aug 15, 2018	SELL	$34.55 - $37.05 $6.7 Million - $7.18 Million	-193,780 Reduced 46.98%	218,674 $7.68 Million
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $2.34 Million - $2.54 Million	73,035 Added 21.52%	412,454 $14.3 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $9.83 Million - $11.5 Million	339,419	339,419 $0

Others Institutions Holding AZN

# of Institutions

1,528

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Astrazeneca PLC Transaction History